These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24930707)

  • 21. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.
    Huijskens EG; Reimerink J; Mulder PG; van Beek J; Meijer A; de Bruin E; Friesema I; de Jong MD; Rimmelzwaan GF; Peeters MF; Rossen JW; Koopmans M
    PLoS One; 2013; 8(1):e54890. PubMed ID: 23365683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus.
    Esposito S; Daleno C; Tagliabue C; Scala A; Picciolli I; Taroni F; Galeone C; Baldanti F; Principi N
    Virol J; 2011 Dec; 8():563. PubMed ID: 22208497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011.
    Rolfes MA; Gross FL; Flannery B; Meyers AFA; Luo M; Bastien N; Fowler RA; Katz JM; Levine MZ; Kumar A; Uyeki TM;
    J Infect Dis; 2018 Mar; 217(7):1078-1088. PubMed ID: 29342251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis.
    Julkunen I; Pyhälä R; Hovi T
    J Virol Methods; 1985 Jan; 10(1):75-84. PubMed ID: 3882733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.
    Fox A; Mai le Q; Thanh le T; Wolbers M; Le Khanh Hang N; Thai PQ; Thi Thu Yen N; Minh Hoa le N; Bryant JE; Duong TN; Thoang DD; Barr IG; Wertheim H; Farrar J; Hien NT; Horby P
    J Infect; 2015 Feb; 70(2):187-96. PubMed ID: 25224643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.
    Chan KH; To KK; Hung IF; Zhang AJ; Chan JF; Cheng VC; Tse H; Che XY; Chen H; Yuen KY
    Clin Vaccine Immunol; 2011 May; 18(5):867-73. PubMed ID: 21411604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Shen HH; Hou J; Zhao M; Xu J; Bai BK; Zhao J; Hu Y; Mao PY; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection.
    Makkoch J; Prachayangprecha S; Payungporn S; Chieochansin T; Songserm T; Amonsin A; Poovorawan Y
    Ann Lab Med; 2012 Jul; 32(4):276-82. PubMed ID: 22779069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
    Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
    BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
    Morrison BJ; Roman JA; Luke TC; Nagabhushana N; Raviprakash K; Williams M; Sun P
    J Virol Methods; 2017 Oct; 248():7-18. PubMed ID: 28624584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic.
    Sandoval C; Barrera A; Ferrés M; Cerda J; Retamal J; García-Sastre A; Medina RA; Hirsch T
    PLoS One; 2016; 11(1):e0147271. PubMed ID: 26799564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
    Clark TW; Pareek M; Hoschler K; Dillon H; Nicholson KG; Groth N; Stephenson I
    N Engl J Med; 2009 Dec; 361(25):2424-35. PubMed ID: 19745215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.
    To KK; Zhang AJ; Hung IF; Xu T; Ip WC; Wong RT; Ng JC; Chan JF; Chan KH; Yuen KY
    Clin Vaccine Immunol; 2012 Jul; 19(7):1012-8. PubMed ID: 22573737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
    Klimova RR; Masalova OV; Burtseva EI; Chichev EV; Lesnova EI; Oskerko TA; Mukasheva EA; Rudneva IA; Lvov DK; Kushch AA
    Vopr Virusol; 2011; 56(3):15-20. PubMed ID: 21786621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
    Chen MI; Barr IG; Koh GC; Lee VJ; Lee CP; Shaw R; Lin C; Yap J; Cook AR; Tan BH; Loh JP; Barkham T; Chow VT; Lin RT; Leo YS
    PLoS One; 2010 Aug; 5(8):e12474. PubMed ID: 20814575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.